Bengbu Fengyuan Pharmaceutical Technology Development

Bengbu Fengyuan Pharmaceutical Technology Development is the primary research and development subsidiary of Anhui Fengyuan Pharmaceutical, a major Chinese pharmaceutical group. The company focuses on the innovation, technical improvement, and consistency evaluation of chemical drugs, active pharmaceutical ingredients (APIs), and biological products. It plays a critical role in supporting the parent company's extensive portfolio, which is particularly strong in large-volume parenteral solutions (IV fluids) and generic medications. The firm's R&D activities span multiple therapeutic areas, including anti-infectives, cardiovascular health, and metabolic disorders. By leveraging advanced pharmaceutical technology, the company ensures that the group's products meet modern regulatory and efficacy standards for both domestic and international markets.